Inventage Lab, a microfluidic drug delivery platform developer, said on Monday that its IVL4002, a recurrence-relieving multiple sclerosis treatment candidate, is scheduled to receive orphan drug designation (ODD) from the Ministry of Food and Drug Safety (MFDS).IVL4002, an investigational relapsing
Hanmi Pharmaceutical's U.S. partner, Spectrum, said that they would “deprioritize” poziotinib, its lung cancer treatment candidate, after receiving a CRL (Complete Response Letter) from the U.S. FDA at 6 a.m. (KST: 9 p.m.) on Friday.Poziotinib aims to treat non-small cell lung cancer (NSCLC) with lo
Daewoong Pharmaceutical held a symposium on Fexuclue, titled “The new wave of GERD (gastroesophageal reflux disease) Treatment,” on Thursday at its headquarters in Samseong-dong, southern Seoul.Thirty-eight “key opinion leaders” from overseas, including the leadership of the Philippine gastrointesti
The Korean Neurocritical Care Society (KNCS) has rolled up its sleeves to prepare for treating critical neurosis patients in the future.The society aims to neurointensivits, specialists who treat those patients, and expand independent neurocritical care units in tertiary general hospitals for the ne
JW Pharmaceutical said Friday that Ministry of Food and Drug Safety(MFDS) approved a multi-country phase 3 trial of epaminurad (pipeline name: URC102), a gout treatment.Epaminurad, developed as an oral pill, is a uric acid transporter-1 (URAT1) inhibitor. The company hopes that it could treat gout d
Qiagen Korea said on Friday it received domestic approval from the Ministry of Food and Drug Safety for Korea's first companion diagnostic (CDx) that can detect FGFR 3 (fibroblast growth factor receptor 3) gene mutations in urothelial cancer patients.On the same day, the MFDS approved Janssen Korea’
The Ministry of Food and Drug Safety approved Janssen Korea’s orphan drug, “Balversa (erdafitinib),” to treat urinary tract epithelial cancer on Thursday.Urinary tract epithelial cancer occurs in the epithelium (surface) of the urinary tract (through which urine passes), mostly in the bladder and oc
Spectrum Pharmaceuticals, Hanmi Pharmaceutical’s U.S. partner, said on Friday that it received a Complete Response Letter (CRL) from the FDA stating that the regulator needs supplementary data to approve poziotinib, a lung cancer treatment.As the FDA notification coincides with the Thanksgiving holi
A recent study is drawing attention, as it said the long-term use of ibuprofen and naproxen, if anything, deteriorated joint inflammation and cartilage quality.The Radiological Society of North America recently foresaw major research results ahead of its academic conference, RSNA 2022. Among them is
Crystal Genomics, a Korean biopharmaceutical firm, said Thursday it has acquired a controlling stake in Pangen Biotech."By purchasing existing shares for 20.4 billion won ($18 million), Crystal Genomics has secured a 20.43 percent stake in Pangen (2,181,818 shares) and became the largest shareholder
GlaxoSmithKline (GSK) said on Wednesday that it released a study on Nucala (mepolizumab) that treats severe eosinophilic asthma in the Asia-Pacific Society for Respirology (APSR) 2022 at Coex, southern Seoul, from Nov. 17-20.Professor Ian Pavord from the University of Oxford made a presentation on r
Reyon Pharmaceutical said on Thursday that it signed a memorandum of understanding (MOU) with Therabest on business cooperation based on the supply of plasmid DNA (pDNA) samples for the development of natural killer (NK) cell therapy.Under the MOU, Therabest will exchange information with Reyon to p
Boryung (formerly Boryung Pharmaceutical) is going all out for the domestic launch of Finjuve Spray, or “sprinkling Propecia,” a hair loss treatment based on finasteride.Boryung plans to release Finjuve Spray next March or April, jumping into the domestic hair loss treatment market as early as the f
HER2-positive breast cancer, which accounts for 20-25 percent of breast cancer, has been known for poor treatment prognosis, as its tumor cells proliferate and metastasize actively and recur quickly even after treatment.However, the cure rate of HER2-positive breast cancer, especially in its early s
JW Pharmaceutical said its U.S. research institute, JW Theriac, moved from San Diego to Cambridge Innovation Center (CIC) in Boston in the U.S.CIC is the world's renowned bio-health industry cluster where over 1,000 global pharmaceutical firms, rising start-ups, hospitals, and research institutions
SK Bioscience shares plummeted Wednesday morning after the company admitted that it had suspended production of SKYCovione, the first domestically developed Covid-19 vaccine.At 12:00 p.m., on Wednesday, SK Bioscience shares stood at 79,500 won ($58.80), down 8.3 from the previous trading day.News re
The one-year grace period granted by the financial regulator to Dx&Vx, a molecular diagnostics company, to improve business irregularities has ended.According to the Korea Exchange (KRX), the improvement period for Dx&Vx ended on Tuesday.Now, Dx&Vx must submit documents detailing how it implemented
Ildong Pharmaceutical said that Japan's Ministry of Health, Labour and Welfare has granted emergency use approval (EUA) for Shionogi & Co’s Xocova, an oral Covid-19 treatment Ildong has been co-developing.Shionogi applied for conditional approval for Xocova to Japan's Ministry of Health, Labor and W
Celltrion Healthcare said multi-country real-world data proved the effectiveness and safety of Truxima (ingredient: rituximab, CT-P10), an anticancer biosimilar, in non-Hodgkin’s lymphoma (NHL) patients. EJHaem, an international academic journal, published a study of the effectiveness and safety of
Takeda Pharmaceutical Korea has proven the efficacy and safety of Ninlaro, a multiple myeloma treatment (ingredient: ixazomib), in Koreans through real-world data.The study included 60 patients who received Ninlaro in combination with two other treatments (ixazomib + lenalidomide + dexamethasone) at